rb 90740 has been researched along with Cell Transformation, Neoplastic in 2 studies
*Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, GE; Hall, EJ; Hei, TK; Laderoute, KR; Langmuir, VK; Liu, SX; Mendonca, HL; Naylor, MA; Sutherland, RM | 1 |
| Hall, EJ; Hei, TK; Liu, SX | 1 |
2 other study(ies) available for rb 90740 and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Fused pyrazine mono-n-oxides as bioreductive drugs. II Cytotoxicity in human cells and oncogenicity in a rodent transformation assay.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Mice; Mice, Inbred C3H; Pyrazines; Radiobiology; Structure-Activity Relationship; Tumor Cells, Cultured | 1996 |
Oncogenic potential of bifunctional bioreductive drugs.
Topics: Animals; Antineoplastic Agents; Aziridines; Cell Survival; Cell Transformation, Neoplastic; Indolequinones; Indoles; Mice; Mice, Inbred C3H; Mitomycin; Oxidation-Reduction; Pyrazines; Structure-Activity Relationship | 1996 |